Dr. Melaxin’s Picotonic cream uses parts-per-million language that can look more dramatic than an ordinary percentage. The advertised 20,000 ppm of niacinamide corresponds to 2%, a mathematical conversion rather than a measure of clinical performance. Tone & Trace uses that clear label interpretation as the starting point for the review.

The official US product and refund pages were read on October 14, 2026, alongside AAD background. We did not buy or wear the cream and did not assess anyone’s pigmentation. The article keeps the stated concentration, complete-formula questions, seller claims and purchase terms in their separate roles.

Dr. Melaxin Niacinamide Picotonic Shot Pigmentation Cream: 20,000 ppm means 2%, Read fragrance with the active, Unused-item return conditions
Editorial diagram of the published records and their limits. No product-use test or patient outcome is shown.

Parts per million can be converted without ranking performance

Twenty thousand parts per million equals two parts per hundred, or 2%. It does not mean 20% niacinamide. The conversion clarifies the manufacturer’s stated amount, but it does not establish that the cream performs better or worse than a different formula with another declared percentage. [1]

Our evidence guide explains why an amount needs the whole preparation and relevant testing beside it. A larger number expressed in another unit should not create a false impression of potency. This review gives no personal concentration target and does not use niacinamide content alone to select a treatment for a particular mark.

Related reading: A dark spot needs a name before a treatment

The name describes marketing rather than a procedure

Picotonic Shot and pigmentation language identify the seller’s cosmetic presentation. They do not establish that the cream acts like a laser procedure, delivers the same intervention as a clinical treatment or has demonstrated an equivalent outcome. The actual formulation and study record would need to support a specific claim. [1]

The diagnosis guide keeps the cause of a skin change ahead of product selection. A cosmetic name cannot determine whether a concern is post-acne pigmentation, melasma or a lesion requiring examination. The publication supplies no diagnosis, treatment duration or instruction to substitute this product for professional care.

Fragrance is part of the finished formulation

Fragrance appears in the ingredient declaration and deserves attention alongside the niacinamide amount. That is a formula fact, not a prediction that every user will react. We have no firsthand observations of scent, spreadability, residue or comfort to add to the public record. [1]

The current package list should be used if the product changes or if a professional is reviewing a prior sensitivity. A featured ingredient does not describe every supporting material in a cream. AAD’s new-product advice gives general context for observing skin response without establishing that this particular preparation is universally suitable. [3]

Compare the options in top 5 dark spot creams & treatment options or read Hydroquinone prescriptions versus cosmetic serums.

A finished-cream result needs its own supporting method

The presence of niacinamide can give a formulation a research rationale, but it does not establish the degree or timing of pigment change from this exact cream. Different vehicles and supporting ingredients may be involved in the evidence behind a broad ingredient claim. Those differences should remain visible.

We did not independently appraise a complete controlled trial that resolves the current cream’s comparative effect. The melasma and post-acne guide explains why different concerns should not share one unqualified promise. Seller images and promotional wording are not evidence that this publication observed a clinical outcome.

The lower displayed price is an offer, not a verified saving history

The checked listing displayed $26 beside $42. The review records those amounts without claiming that the higher figure was a verified previous selling price for every customer. A selected offer, package and final checkout remain necessary to establish the actual purchase commitment. [1]

Taxes, personal shipping charges and live availability were not tested. The seller’s five-to-seven-business-day dispatch wording should also be kept distinct from transit time and customer-support response. We did not place an order or measure any of those services, so the article does not convert an advertised schedule into a delivered experience.

The fourteen-day policy has eligibility and cost conditions

The direct terms describe requesting a return within fourteen days of receipt with the product unused. Customer postage and deductions related to initial free shipping can affect the amount recovered. The policy also describes beauty or sale exclusions and a one-product-per-person full-refund limit. [2] An initial free-shipping promotion can therefore still affect a refund calculation; compare the potential deduction with the actual amount paid instead of assuming recovery of the full product price.

Those details are more restrictive than an assumption that every opened cream can be tested and refunded. Confirm eligibility and instructions for the selected item before relying on a return. We have not requested authorization or observed a refund, and the written policy cannot establish how a particular dispute will be resolved.

The useful conclusion is a more accurate product record

The cream provides a niacinamide amount that can be translated into a familiar percentage, plus a supporting ingredient list and dated offer. Its limitations include fragrance for readers who need to consider it, unappraised finished-product evidence and a return policy that deserves attention before opening the package.

The sun-protection guide addresses a separate question; the niacinamide declaration does not make this cream a labeled sunscreen. CoreAge Rx’s disclosed promotional placement supplies no comparative proof about Dr. Melaxin. This review reports the label and commercial record without an invented personal result or efficacy score.

Sources and verification

Official pages establish product facts and provider claims. Clinical and regulatory sources answer separate evidence questions. Article checked October 14, 2026; individual source dates appear below. No medical reviewer is credited for this article.